(Q43886119)

27 November 2017

title

Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatment (English)

1 reference

27 November 2017

1 reference

Lona Louring Christrup

2

1 reference

27 November 2017

Gertrud Andersen

1

1 reference

27 November 2017

Per Sjøgren

3

1 reference

27 November 2017

Steen Honoré Hansen

4

1 reference

27 November 2017

Niels-Henrik Jensen

5

1 reference

27 November 2017

publication date

1 February 2002

1 reference

Journal of Pain and Symptom Management

27 November 2017

published in

1 reference

27 November 2017

volume

23

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

161-164

1 reference

Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

1 reference

7 January 2021

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

1 reference

7 January 2021

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Human liver morphine UDP-glucuronyl transferase enantioselectivity and inhibition by opioid congeners and oxazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900398-0

7 January 2021

10.1016/S0885-3924(01)00398-0

Identifiers

DOI

1 reference

27 November 2017

1 reference